Provided by Tiger Trade Technology Pte. Ltd.

LEPU BIO

4.060
+0.1353.44%
Volume:8.50M
Turnover:34.16M
Market Cap:7.32B
PE:23.27
High:4.090
Open:4.010
Low:3.955
Close:3.925
52wk High:8.110
52wk Low:3.550
Shares:1.80B
HK Float Shares:1.80B
Volume Ratio:1.02
T/O Rate:0.47%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.174
ROE:24.24%
ROA:-0.07%
PB:4.42
PE(LYR):23.27
PS:6.31

Loading ...

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

LEPU BIO Shares Surge Over 13% in Morning Session as Analyst Highlights Potential of MRG006A in Liver Cancer Treatment

Stock News
·
Jun 29

LEPU BIO Shares Surge Over 6% in Afternoon Trading on Promising Liver Cancer Drug Data

Stock News
·
Jun 12

LEPU BIO-B Maintains 1.80 Billion Issued Shares in May 2026; Public Float Remains Compliant

Bulletin Express
·
Jun 01

Lepu Biopharma Updates Articles of Association; Registered Capital Set at RMB 1.80 Billion

Bulletin Express
·
May 19

LEPU Biopharma Shareholders Endorse All 2025 AGM Items, Confirm New Supervisor and Shanghai Registered Address

Bulletin Express
·
May 19

LEPU BIO-B (02157) Appoints Fan Xinyu as Supervisory Board Member

Stock News
·
May 19

TOT BIOPHARM publishes 2025 annual report

Reuters
·
Apr 28

Lepu Bio-B Proposes Appointment of Fan Xinyu as Supervisor

Stock News
·
Apr 27

LEPU BIO-B Releases 2025 Board Package, Maintains Zero Dividend and Seeks 20% Share Issuance Mandate

Bulletin Express
·
Apr 27

Lepu Biopharma announces annual shareholder meeting

Reuters
·
Apr 27

乐普生物2025年营收显著增长并成功扭亏为盈

Bulletin Express
·
Apr 22

Lepu Biopharma publishes 2025 annual report

Reuters
·
Apr 22

Assessing Lepu Biopharma’s Valuation After Earnings Turnaround And Share Price Surge

Simply Wall St.
·
Apr 06

LEPU BIO-B Posts March 2026 Monthly Return: 1.80 Bln Shares Outstanding, No Capital Changes

Bulletin Express
·
Apr 02

Assessing Lepu Biopharma (SEHK:2157) Valuation After Its Earnings Turnaround And Recent Share Price Strength

Simply Wall St.
·
Mar 28

HK Pharma Stocks Gained. CSPC Pharma Up 13%; Lepu Bio Up 7%; Hengrui Pharma And Junshi Bio Up 6%; HBM, Beigene, Sihuan Pharm Up 5%

Tiger Newspress
·
Mar 27

Lepu Biopharma (SEHK:2157) Profit Swing To C¥41.7m Tests Bearish Earnings Narratives

Simply Wall St.
·
Mar 26

Stock Track | LEPU BIO-B Soars 14.84% Intraday on Strong Annual Results Showing Revenue Surge and Profit Turnaround

Stock Track
·
Mar 26

Robust Earnings Fuel Continued Gains for Hong Kong Stock Connect Biotech ETFs Amid Market Downturn

Deep News
·
Mar 26